| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |